Search results
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Benzinga via Yahoo Finance· 1 year agoGenentech, a unit of Roche Holdings AG (OTC: RHHBY), announced that the Phase 3 IMbrave050 study met...
Biotech Giant Regeneron Hit As Eylea Gives Ground To Avastin
Investor's Business Daily· 1 year agoBiotech giant Regeneron Pharmaceuticals said Monday that sales of its linchpin Eylea drug in the...
The Many Reinventions of a Legendary Washington Influence Peddler
Politico via Yahoo Finance· 1 month agoOn the morning after Election Day of 2016, as Washington’s political establishment absorbed the shock of Donald Trump’s victory, one veteran Republican operative was already hard at work. Jim ...
Roche's (RHHBY) Application for PNH Drug Accepted by FDA
Zacks via Yahoo Finance· 9 months agoRoche Group RHHBY member Genentech has received a significant boost following the acceptance of its...
Roche looking to sell or shut down California biologic drug plant
Reuters via Yahoo News· 1 year agoSwiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in...
US sues Regeneron, alleging false price reporting on Eylea
BioPharma Dive via Yahoo Finance· 2 months agoThe lawsuit claims the drugmaker didn’t disclose reimbursement to drug distributors for credit card...
Roche (RHHBY) Gets FDA Approval for Blood Cancer Drug Columvi
Zacks via Yahoo Finance· 12 months agoRoche's (RHHBY) blood cancer portfolio gets a boost with the approval of Columvi (glofitamab-gxbm)...
UPDATE 1-Roche looking to sell Vacaville, California plant
Reuters via Yahoo Finance· 1 year agoSwiss drugmaker Roche Holding AG plans to sell or close its drug manufacturing plant in Vacaville, California, or it will shut the factory down by 2029, according to e-mailed letters to the ...
Top 15 Best-Selling Cancer Drugs
Insider Monkey via Yahoo Finance· 4 months agoIn this article, we will be discussing the top 15 best-selling cancer drugs. If you are not interested in reading about the global cancer treatment...